This compound is an Fmoc-protected amino acid derivative used as a linker in solid-phase peptide synthesis. It features a carboxylic acid group and multiple aromatic rings, contributing to its utility in pharmaceutical intermediate manufacturing.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 126828-35-1
Carbamic acid, ((4-(2-((bis(4-methylphenyl)methyl)amino)-2-oxoethoxy)phenyl)(2,4-dimethoxyphenyl)methyl)-, 9H-fluoren-9-ylmethyl ester
peptide synthesis intermediate
Calcipotriol, anhydrous impurity A
Pharmaceutical impurity reference standard
3,17-Diiodoandrosta-3,5,16-triene
Abiraterone acetate impurity intermediate
(R)-2-((6-(3-((3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile
Pharmaceutical intermediate for alogliptin
N-4-Boc-N-1-Cbz-2-piperazine carboxylic acid
Pharmaceutical intermediate with orthogonal protecting groups
2-[4-[(2,4-dimethoxyphenyl)-(9H-fluoren-9-ylmethoxycarbonylamino)methyl]phenoxy]acetic acid
UPMGJEMWPQOACJ-UHFFFAOYSA-N
COC1=CC(=C(C=C1)C(C2=CC=C(C=C2)OCC(=O)O)NC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35)OC